Simplify Stelara Prior Authorization with Klivira

Klivira automates the complex process of Stelara prior authorization, ensuring your team can focus on patient care rather than administrative bottlenecks.

Managing prior authorizations for high-cost specialty biologics like Stelara (ustekinumab) presents significant operational challenges for revenue cycle directors and prior authorization coordinators. The stringent criteria and documentation demands for this IL-12/23 inhibitor often lead to delays, appeals, and increased administrative overhead, impacting both clinic efficiency and patient access to critical therapies.

Navigating the Complexity of Stelara Prior Authorization

Stelara, an IL-12/23 inhibitor indicated for conditions such as psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis, requires meticulous documentation to meet payer-specific criteria. Manual processes for ustekinumab often involve extensive chart review, form completion, and multiple follow-ups, consuming valuable staff time and potentially delaying patient treatment initiation.

Common Prior Authorization Hurdles for Ustekinumab

Demonstrating medical necessity against specific payer criteria
Gathering comprehensive clinical documentation (e.g., failed prior therapies)
Coordinating information across EMRs, payer portals, and patient records
Managing appeals for initial denials
Tracking authorization status and expiration dates

Klivira's Automated Approach to Stelara Prior Authorization

Klivira streamlines the entire Stelara prior authorization workflow by leveraging intelligent automation and deep integration capabilities. Our platform extracts necessary clinical data directly from your EMR, populates payer-specific forms, and manages submission via X12 278, ePA, or payer portals, significantly reducing manual intervention and accelerating approval times.

Seamless EMR Integration and Secure Data Exchange

Klivira integrates with your existing EMR systems, including those supporting SMART on FHIR, to ensure secure and efficient exchange of PHI required for Stelara prior authorization. This robust integration minimizes data entry errors, enhances data accuracy, and maintains compliance with HIPAA standards, while supporting Da Vinci PAS and NCPDP SCRIPT standards where applicable.

Operational Benefits for Your Revenue Cycle Team

Reduced administrative burden on PA coordinators
Improved turnaround times for Stelara approvals
Enhanced visibility into authorization status
Fewer denials and appeals related to incomplete documentation
Optimized resource allocation within your revenue cycle department

Compliance and Audit Readiness

Klivira’s platform maintains a comprehensive audit trail of all prior authorization activities, supporting your organization's compliance efforts. Discuss with your compliance team how an automated solution aligns with regulatory requirements, including those outlined in CMS-0057-F, to ensure robust and defensible PA processes.

Frequently asked questions

How does Klivira handle payer-specific criteria for Stelara?

Klivira's platform incorporates a dynamic rules engine that is regularly updated with payer-specific medical policies for Stelara (ustekinumab). It guides the PA coordinator to gather the precise clinical data points required by each individual payer, ensuring submissions meet specific criteria and minimize rejections.

Can Klivira integrate with our current EMR for Stelara PA data?

Yes, Klivira is designed for deep integration with major EMR systems. We support various integration methods, including SMART on FHIR, to securely extract relevant patient data for Stelara prior authorizations directly from your EMR, reducing manual data entry and improving accuracy.

What is the typical implementation timeline for Klivira for Stelara authorizations?

Implementation timelines vary based on the complexity of your existing infrastructure and the scope of integration. Our team works closely with your IT integration leads to ensure a smooth and efficient rollout, often achieving initial operational capability within weeks.

How does Klivira help reduce Stelara PA denials?

By ensuring all required clinical documentation is systematically gathered and accurately submitted according to payer guidelines, Klivira significantly reduces the likelihood of denials due to incomplete information or non-compliance with medical necessity criteria for ustekinumab. This proactive approach minimizes the need for appeals.

Does Klivira support both initial and renewal Stelara prior authorizations?

Yes, Klivira supports the entire lifecycle of Stelara prior authorizations, including initial submissions, renewals, and appeals. The platform helps track authorization expiration dates and proactively initiates renewal processes to prevent lapses in coverage.